NCT06243406View on ClinicalTrials.gov

Study on the Biomarkers of Anti-VEGF Treatment for Choroidal Neovascularization

Not yet recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

February 10, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

October 31, 2024

Conditions
Choroidal Neovascularization
Interventions
OTHER

Intravitreal injection of anti-VEGF

Intravitreal injection of anti- vascular endothelial growth factor (VEGF) treatment

All Listed Sponsors
lead

Beijing Hospital

OTHER_GOV

NCT06243406 - Study on the Biomarkers of Anti-VEGF Treatment for Choroidal Neovascularization | Biotech Hunter | Biotech Hunter